Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 40 min ago

US National Security, China and Biotechnology in 2024

Sat, 05/04/2024 - 02:00
US National Security, China and Biotechnology in 2024 4/5/2024

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS

Sat, 05/04/2024 - 02:00
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS 4/5/2024

FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy

Sat, 05/04/2024 - 02:00
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy 4/5/2024

Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters

Sat, 05/04/2024 - 02:00
Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters 4/5/2024

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data

Sat, 05/04/2024 - 02:00
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data 4/5/2024

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US

Fri, 04/19/2024 - 02:00
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies

Fri, 04/19/2024 - 02:00
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC

Fri, 04/19/2024 - 02:00
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring

Fri, 04/19/2024 - 02:00
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?

Fri, 04/19/2024 - 02:00
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Fri, 04/19/2024 - 02:00
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff

Fri, 04/19/2024 - 02:00
Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff 4/19/2024

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC

Fri, 04/19/2024 - 02:00
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC 4/19/2024

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market

Thu, 04/18/2024 - 02:00
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win

Thu, 04/18/2024 - 02:00
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition

Thu, 04/18/2024 - 02:00
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA

Thu, 04/18/2024 - 02:00
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch

Thu, 04/18/2024 - 02:00
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS

Thu, 04/18/2024 - 02:00
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles

Thu, 04/18/2024 - 02:00
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024